RedC Biotech is a pre-clinical, development stage company aiming at saving lives worldwide. RedC is developing a new, process, to create universal red blood cells from stem cells using a patented cultivation technology. It is a highly scalable process for production that can meet the global demand for safe red blood cell transfusions for anyone, anywhere. The universal red blood cells provided by RedC Biotech will be a blood type that is suitable for almost every patient and will have the same potency as the currently used red blood cell transfusion RedC Biotech collaborates with leading industry, academia and government organizations.